Business Wire - Teva Announces Approval of Glipizide and Metformin HCL Tablets
October 31, 2005 -- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced that the U.S. Food and Drug Administration has granted final approval...
Business Wire - Teva Announces Approval of Metformin HCl ER Tablets
June 18, 2004 -- JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final...
Business Wire - Teva Announces Approval of Metformin HCl Extended Release Tablets, 750 mg
April 13, 2005 -- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval...
Business Wire - Eon Labs Receives Approval for Metformin HCl
January 25, 2002 -- Business Editors & Health/Medical Writers NEW YORK--(BUSINESS WIRE)--Jan. 25, 2002 Eon Labs Manufacturing, Inc. announced today that they...
Business Wire - Mylan Receives Approval for Metformin HCl Tablets
January 25, 2002 -- Business Editors PITTSBURGH--(BUSINESS WIRE)--Jan. 25, 2002 Mylan Laboratories Inc. (NYSE:MYL) announced today that the Food and Drug...
Market Wire - ACTOplus met(TM) (pioglitazone HCl and metformin HCl) Now Available in U.S. Pharmacies
November 1, 2005 -- Takeda Pharmaceuticals North America, Inc.today announced that ACTOplus met(TM) (pioglitazone HCl and metformin HCl)is now available by prescription...
Market Wire - ACTOplus met(TM) (pioglitazone HCl and metformin HCl) Approved by the FDA for Type 2 Diabetes
August 29, 2005 -- Takeda Pharmaceuticals North America, Inc.(TPNA) today announced that the U.S. Food and Drug Administration (FDA) hasapproved the New Drug...
Market Wire - Takeda Submits New Drug Application for Extended-Release Type 2 Diabetes Medication, ACTOplus met(TM) (pioglitazone HCl and metformin HCl)
April 3, 2006 -- Takeda Global Research & DevelopmentCenter (TGR&D) today announced that the company has submitted a New DrugApplication (NDA) for an...
Business Wire - Teva Announces Tentative Approval of Metformin HCl Extended-Release Tablets
March 26, 2003 -- Business Editors/Health/Medical Writers JERUSALEM--(BUSINESS WIRE)--March 26, 2003 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced...
Business Wire - Andrx Announces Approval of Metformin HCl Extended-Release Tablets, 750mg
April 13, 2005 -- FORT LAUDERDALE, Fla. -- Andrx Corporation (Nasdaq:ADRX) today announced that the United States Food and Drug Administration has granted final...
